Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Complementary meta-analyses showed higher total 1,25(OH)2D and modestly lower free 25(OH)D concentrations during pregnancy; sensitivity analyses excluding the current cohort yielded similar overall patterns.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis reported · Blinding unclear / not reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

We conducted a large real-world laboratory-based cross-sectional study using routine clinical data from women aged 18 to 45 years tested at a German diagnostic center between 2014 and 2020.

Source: Abstract.

We conducted a large real-world laboratory-based cross-sectional study using routine clinical data from women aged 18 to 45 years tested at a German diagnostic center between 2014 and 2020.

Source: Abstract.

A random-effects meta-analysis was conducted to compare circulating free 25(OH)D and total 1,25(OH)2D concentrations between pregnant and nonpregnant women.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Pregnancy-associated alterations in circulating vitamin D metabolites: higher total 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D without increased free 25-hydroxyvitamin D

Cross-sectional study · Frontiers in Endocrinology · 2026

Original publication title

Pregnancy-associated alterations in circulating vitamin D metabolites: higher total 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D without increased free 25-hydroxyvitamin D

Hui-fang Zhang; Xin Chen; Jia-yi Xiang; Ze-yu Zhang; Yvonne Liu; Katrin Huesker; Volker von Baehr; Saban Elitok; Bernhard Karl Krämer; Christoph Reichetzeder; Berthold Hocher

Copyright © 2026 Zhang, Chen, Xiang, Zhang, Liu, Huesker, von Baehr, Elitok, Krämer, Reichetzeder and Hocher.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Pregnancy was associated with higher total 25(OH)D and markedly higher total 1,25(OH)2D. No statistically significant difference in free 25(OH)D was detected in the much smaller available subgroup; this finding should be considered exploratory and requires confirmation in larger studies. These results highlight the importance of analyte-specific interpretation of vitamin D biomarkers during pregnancy.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Interpretation of vitamin D biomarkers during pregnancy remains challenging because physiological adaptations alter total and free vitamin D metabolites differently, while evidence comparing multiple circulating vitamin D metabolites within the same clinical setting remains limited.

Source: Background

Abstract: What methods does the paper describe?

We conducted a large real-world laboratory-based cross-sectional study using routine clinical data from women aged 18 to 45 years tested at a German diagnostic center between 2014 and 2020. Total 25-hydroxyvitamin D [25(OH)D], free 25-hydroxyvitamin D, and total 1,25-dihydroxyvitamin D [1,25(OH)2D] concentrations were compared between pregnant and nonpregnant women and across gestation using age-adjusted regression models. Complementary random-effects meta-analyses were performed for free 25-hydroxyvitamin D and total 1,25-dihydroxyvitamin D.

Source: Methods

Abstract: Results

After exclusions, 101,454 nonpregnant and 16,017 pregnant women comprised the overall study population, with analyte-specific sample sizes reflecting availability in routine clinical practice. In age-adjusted analyses, pregnancy was associated with higher total 25(OH)D concentrations (adjusted difference 22.07 nmol/L; 95% CI, 21.50 to 22.63; P<0.001) and markedly higher total 1,25(OH)2D concentrations (adjusted difference 125.20 pmol/L; 95% CI, 115.39 to 135.02; P<0.001). Both metabolites were higher at later gestational stages in cross-sectional analyses. In contrast, directly measured free 25(OH)D did not differ significantly between pregnant and nonpregnant women (adjusted difference, -2.63 pmol/L; 95% CI, -8.99 to 3.74; P = 0.417).

Complementary meta-analyses showed higher total 1,25(OH)2D and modestly lower free 25(OH)D concentrations during pregnancy; sensitivity analyses excluding the current cohort yielded similar overall patterns.

Source: Results

Abstract: Conclusions

Pregnancy was associated with higher total 25(OH)D and markedly higher total 1,25(OH)2D. No statistically significant difference in free 25(OH)D was detected in the much smaller available subgroup; this finding should be considered exploratory and requires confirmation in larger studies. These results highlight the importance of analyte-specific interpretation of vitamin D biomarkers during pregnancy.

Source: Conclusions
Authors’ abstract

Background

Interpretation of vitamin D biomarkers during pregnancy remains challenging because physiological adaptations alter total and free vitamin D metabolites differently, while evidence comparing multiple circulating vitamin D metabolites within the same clinical setting remains limited.

Methods

We conducted a large real-world laboratory-based cross-sectional study using routine clinical data from women aged 18 to 45 years tested at a German diagnostic center between 2014 and 2020. Total 25-hydroxyvitamin D [25(OH)D], free 25-hydroxyvitamin D, and total 1,25-dihydroxyvitamin D [1,25(OH)2D] concentrations were compared between pregnant and nonpregnant women and across gestation using age-adjusted regression models. Complementary random-effects meta-analyses were performed for free 25-hydroxyvitamin D and total 1,25-dihydroxyvitamin D.

Results

After exclusions, 101,454 nonpregnant and 16,017 pregnant women comprised the overall study population, with analyte-specific sample sizes reflecting availability in routine clinical practice. In age-adjusted analyses, pregnancy was associated with higher total 25(OH)D concentrations (adjusted difference 22.07 nmol/L; 95% CI, 21.50 to 22.63; P<0.001) and markedly higher total 1,25(OH)2D concentrations (adjusted difference 125.20 pmol/L; 95% CI, 115.39 to 135.02; P<0.001). Both metabolites were higher at later gestational stages in cross-sectional analyses. In contrast, directly measured free 25(OH)D did not differ significantly between pregnant and nonpregnant women (adjusted difference, -2.63 pmol/L; 95% CI, -8.99 to 3.74; P = 0.417).

Complementary meta-analyses showed higher total 1,25(OH)2D and modestly lower free 25(OH)D concentrations during pregnancy; sensitivity analyses excluding the current cohort yielded similar overall patterns.

Conclusions

Pregnancy was associated with higher total 25(OH)D and markedly higher total 1,25(OH)2D. No statistically significant difference in free 25(OH)D was detected in the much smaller available subgroup; this finding should be considered exploratory and requires confirmation in larger studies. These results highlight the importance of analyte-specific interpretation of vitamin D biomarkers during pregnancy.

Publication and source details

Original title: Pregnancy-associated alterations in circulating vitamin D metabolites: higher total 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D without increased free 25-hydroxyvitamin D

Hui-fang Zhang; Xin Chen; Jia-yi Xiang; Ze-yu Zhang; Yvonne Liu; Katrin Huesker; Volker von Baehr; Saban Elitok; Bernhard Karl Krämer; Christoph Reichetzeder; Berthold Hocher

Frontiers in Endocrinology · 2026

* Correspondence: Berthold Hocher, berthold.hocher@medma.uni-heidelberg.de; Christoph Reichetzeder, christoph.reichetzeder@hmu-potsdam.de

†ORCID: Hui-fang Zhang, orcid.org/0009-0009-7013-9546; Xin Chen, orcid.org/0000-0003-4997-1257; Christoph Reichetzeder, orcid.org/0000-0002-2219-5529; Berthold Hocher, orcid.org/0000-0001-8143-0579

†These authors have contributed equally to this work and share first authorship

Copyright © 2026 Zhang, Chen, Xiang, Zhang, Liu, Huesker, von Baehr, Elitok, Krämer, Reichetzeder and Hocher.2026Zhang, Chen, Xiang, Zhang, Liu, Huesker, von Baehr, Elitok, Krämer, Reichetzeder and Hocherhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-09T14:55:04.034447+00:00

DOI: 10.3389/fendo.2026.1957418 · PMC13735605